Perampanel as a candidate for polytherapy in Stage 1 Plus status epilepticus: biological rationale and translational limits

Giuseppe Magro, Oreste Marsico, Adriana Saraceno, Federico Tosto

Open source

DOI
10.1007/s10072-026-09422-5
Published
2026-09-24
Container
Neurological Sciences
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10072-026-09422-5,
  title = {Perampanel as a candidate for polytherapy in Stage 1 Plus status epilepticus: biological rationale and translational limits},
  author = {Giuseppe Magro and Oreste Marsico and Adriana Saraceno and Federico Tosto},
  year = {2026},
  journal = {Neurological Sciences},
  doi = {10.1007/s10072-026-09422-5},
  url = {https://doi.org/10.1007/s10072-026-09422-5}
}

RIS

TY  - JOUR
TI  - Perampanel as a candidate for polytherapy in Stage 1 Plus status epilepticus: biological rationale and translational limits
AU  - Giuseppe Magro
AU  - Oreste Marsico
AU  - Adriana Saraceno
AU  - Federico Tosto
PY  - 2026
JO  - Neurological Sciences
DO  - 10.1007/s10072-026-09422-5
UR  - https://doi.org/10.1007/s10072-026-09422-5
ER  - 

APA

Magro, G., Marsico, O., Saraceno, A., & Tosto, F. (2026). Perampanel as a candidate for polytherapy in Stage 1 Plus status epilepticus: biological rationale and translational limits. Neurological Sciences. https://doi.org/10.1007/s10072-026-09422-5

Source records